Amgen Inc Earnings
The next earnings date for Amgen Inc has not yet been scheduled.
Analyst Estimates of Amgen Inc Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Amgen Inc Earnings: Historical
| 08/04/2026 | After Market | $6.29 | 12.32% |
| 04/30/2026 | After Market | $5.15 | 7.97% |
| 02/03/2026 | After Market | $5.29 | 11.84% |
| 11/04/2025 | After Market | $5.64 | 12.57% |
| 08/05/2025 | After Market | $6.02 | 14.02% |
| 05/01/2025 | After Market | $4.90 | 15.02% |
| 02/04/2025 | After Market | $5.31 | 4.53% |
| 10/30/2024 | After Market | $5.58 | 9.20% |
| 08/06/2024 | After Market | $4.97 | -0.60% |
| 05/02/2024 | After Market | $3.96 | 1.80% |
More About Amgen Inc
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is he
“Amgen Inc Earnings” Can Refer to the Amgen Inc Earnings Date
Some people say “Amgen Inc earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Amgen Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Amgen Inc Stock on the Earnings Date
If you own Amgen Inc stock (AMGN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Amgen Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Amgen Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Owning Amgen Inc Options on the Earnings Date
If you own Amgen Inc options on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
In addition, the extrinsic values of Amgen Inc options that overlap earnings dates are often higher than other days of the year. In other words, the premiums you pay to own Amgen Inc options are typically higher during that period. In particular, they are frequently higher immediately before earnings and on the day they’re announced.
This makes sense considering that prices are often more volatile on earnings dates for Amgen Inc. That potential volatility is a key factor that affects the premium cost of owning options.
Once the earnings announcement is done and the anticipated price volatility has gone down, the extrinsic values of Amgen Inc options often go down. This is sometimes referred to as volatility crush.
Learning More Amgen Inc Earnings
You can contact us any time if you would like to ask questions about Amgen Inc earnings or anything else related to the stock market.